How long do you continue caplacizumab in relapsed refractory TTP?

How often do you monitor ADAMTS-13 levels off therapy?

Answer from: at Community Practice

While there are no data from studies to guide our answer, general practice is to continue caplacizumab until the ADAMTS13 activity is at least 20% on two occasions, or greater than 30% assuming it was measured at least 4-5 days after the last plasma exchange procedure. The goal is to have stable rec...

Comments

Medical Oncologist at Florida Cancer Specialists and Research Institute
There are some patients due to persistent antibodi...

at Kaiser Permanente, Los Angeles Med Center
Thank you so much for your expertise, Dr. @Spero C...

Please select the option that best describes you:

How long do you continue caplacizumab in relapsed refractory TTP?

Related Questions